http://orcid.org/0000-0003-2696-5129
Figures
Abstract
Burn injury detrimentally affects the myocardium, primarily due to over-activation of β-adrenergic receptors (β-AR). Autopsy reports from our institution reveal that patients often suffer from right ventricle (RV) failure. Since burn injury affects β-AR signaling in the left ventricle (LV), we proposed that β-AR signaling may also be altered in the RV. A rodent model with a scald burn of 60% of the total body surface area was used to test this hypothesis. Ventricles were isolated 7 days post-burn. We examined the expression of β-ARs via Western blotting and the mRNA expression of downstream signaling proteins via qRT-PCR. Cyclic adenosine monophosphate (cAMP) production and protein kinase A (PKA) activity were measured in membrane and cytosolic fractions, respectively, using enzyme immunoassay kits. β1-AR protein expression was significantly increased in the RV following burn injury compared to non-burned RV but not in the LV (p = 0.0022). In contrast, β2-AR expression was unaltered among the groups while Gαi expression was significantly higher in the LV post-burn (p = 0.023). B-arrestin-1 and G-protein coupled receptor kinase-2 mRNA expression were significantly increased in the left ventricle post-burn (p = 0.001, p<0.0001, respectively). cAMP production and PKA activity were significantly lower in the LV post-burn (p = 0.0063, 0.0042, respectively). These data indicate that burn injury affects the β-AR signaling pathway in the RV independently of the LV. Additionally, non-canonical β-AR signaling may be activated in the RV as cAMP production and PKA activity were unchanged despite changes in β1-AR protein expression.
Citation: Guillory AN, Clayton RP, Prasai A, El Ayadi A, Herndon DN, Finnerty CC (2017) Biventricular differences in β-adrenergic receptor signaling following burn injury. PLoS ONE 12(12): e0189527. https://doi.org/10.1371/journal.pone.0189527
Editor: Kjetil Tasken, University of Oslo, NORWAY
Received: August 1, 2017; Accepted: November 26, 2017; Published: December 12, 2017
Copyright: © 2017 Guillory et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are contained within the paper and its Supporting Information files.
Funding: This study was supported by grants from the National Institutes of Health (P50-GM60338 [DNH], R01GM056687 [DNH], R01GM112936 [CCF]; https://www.nih.gov/) and Shriners Hospitals for Children (80100 [DNH], 84291 [CCF], 80500 [DNH], 84202 [CCF], 71001 [DNH]; https://www.shrinershospitalsforchildren.org/). This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1RR029876 [awarded to Allen Brasier, UTMB) from the National Center for Advancing Translational Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Cardiovascular dysfunction after severe burn injury has been demonstrated clinically in patients as well as in rodent and mammalian burn models. [1, 2] However, the molecular mechanisms underlying this cardiac dysfunction are not clearly defined. We have shown in severely burned pediatric patients that the release of the catecholamines epinephrine and norepinephrine are significantly enhanced after injury and this increase in release is associated with perturbations of heart rate and cardiac work. [2, 3] Additionally, autopsy reports from our institution indicate that many pediatric patients present with right heart failure. [4]
Circulating catecholamines activate myocardial adrenergic receptors to modulate cardiac function. [5] Increased catecholamine levels contribute to the development and progression of cardiac dysfunction in several disease states, including heart failure. [6, 7] While there are several types of adrenergic receptors in the heart, altered catecholamine levels’ effect on β1- and β2-adrenergic receptor (β1-AR, β2-AR) signaling has been well studied in various non-burned states. Overstimulation of β-ARs by catecholamines results in dysregulation of the associated signaling pathways. Among other things, there can be desensitization of the receptors, altered protein phosphorylation, and activation of alternate signaling pathways. [8]
Both right and left ventricles predominately express β-ARs, but α-adrenergic receptors also modulate cardiac function. It has also been hypothesized that the right ventricle is more dependent upon α-adrenergic receptor activity than the left ventricle. The right and left ventricles respond to catecholamine administration in vastly different manners. Irlbeck et al., reported that norepinephrine infusion resulted in altered right ventricular hemodynamics but left ventricular hypertrophy. [9] The two ventricles develop from different cellular lineages, which may partially explain why each ventricle responds differently to stimuli. Based on the clinical and basic science evidence, we hypothesized that burn injury would affect β-AR signaling differentially in the left and right ventricles.
Methods
Animal model of burn injury
The Institutional Animal Care and Use Committee of University of Texas Medical Branch-Galveston in accordance with the National Institutes of Health Guide for the Care and use of Laboratory Animals approved this study’s protocol (Protocol#:0506032). A full-thickness scald was induced in male Sprague-Dawley rats as previously described. [10, 11] Briefly, rats (n = 9–12 per group) were acclimated for 1 week in the animal care facility prior to experimentation. Animal subjects were housed under standard laboratory conditions with water and food available ad libitum. Prior to the burn, all animals (control and burn) received 0.05mg/kg Buprenorphine. 1–3% isoflurane in air was used to induce general anesthesia. Sufficient depth of anesthesia was determined using the toe pinch method with nonserrated forceps. A scald burn covering 60% of the total body surface area was administered to the shaved dorsal and lateral surfaces. Resuscitation was achieved with administration of 40ml/kg Lactated Ringers solution. Animals were recovered with oxygen under observation and placed in wire bottom cages for the duration of the experiment. Animals were housed individually to prevent barbering and reduce infection. Laboratory personnel and veterinary staff rounded on animals several times daily. If a sufficient score on the pain scale was observed, 0.05 mg/kg Buprenorphine was administered every 8–12 hours until pain was no longer evident. At the conclusion of the study, animals were euthanized via decapitation without anesthesia.
Experimental design
The groups for this experiment were control and burn. Control animals received analgesia, anesthesia, and were shaved but did not undergo the burn procedure or resuscitation. We chose 7 days post-burn as the study period because of previously published data showing that there were alterations in β-ARs, cyclic adenosine monophosphate (cAMP) production, and protein kinase A (PKA) activity 1 week after burn injury. [12]
Western blotting
β1-AR, β2-AR, β3-AR (Santa Cruz Biotechnology, Santa Cruz, CA), Gαs, Gαi, and GAPDH (Cell Signaling Technology, Danvers, MA) protein expression was determined via Western Blot analysis. Thirty micrograms of left and right ventricular homogenates were resolved on SDS-PAGE gradient gels (4–15%, Tris-Glycine) and transferred to polyvinylidine difluoride membranes. Primary antibody incubation occurred at 4°C for a minimum of 16 hours. Blots were then washed with 0.1% TBST, followed by incubation with anti-HRP secondary antibodies (Cell Signaling) for a minimum of 1 hour at room temperature. Band intensities were visualized using chemiluminescence (SuperSignal West Pico Chemiluminescent Substrate, Thermo Scientific, Rockford, IL, USA) and quantified using NIH ImageJ Data Acquisition Software (National Institutes of Health, Bethesda, MD, USA).
Enzyme immunoassay kits
cAMP production and PKA activity were measured using commerically available kits from Enzo LifeSciences, Ann Arbor, MI. Aliquots of 30ug of ventricular membrane fraction was used to determine cAMP production as previously described. [13] Experiments were performed in duplicate and the amount of cAMP produced (pmols) was normalized to the protein concentration of each sample. PKA activity was determined in 20ugs of ventricular cytosolic fractions via an enzyme immunoassay kit (Enzo LifeSciences, Ann Arbor, MI). Nonspeicifc kinase activity was determined by utilizing10μM peptide inhibitor of PKA (PKI). Experiments were performed in triplicate and the relative kinase activity was normalized to the protein concentration of each sample.
Quantitative-Real Time-PCR (qRT-PCR)
Left and right ventricular tissue was homogenized and RNA extracted using Ambion TRIzol Reagent (Life Technologies/ThermoFisher Scientific, Waltham, MA) and the RNeasy Mini Kit (Qiagen, Frederick, MD). cDNA was generated using 250ng of purified RNA and the iScript cDNA Synthesis Kit (Bio-Rad Laboratory, Hercules, CA). cDNA products were amplified in triplicate using 10ul iTaq Universal SYBR Green Supermix and 400nm primer mix to a total volume of 20ul (Table 1). Samples were normalized to ribosomal protein L13a (Rpl13a). Data are expressed as fold change compared to controls using the comparative CT method. [14] Two validations were performed to ensure that there was no genomic DNA amplification. First, the melting curve was performed and analyzed to ensure that only peak was observed per gene of interest. Secondly, following the PCR amplification, gel electrophoresis was performed and a single band was observed in the gel.
Results
β-AR and G-protein expression is altered differentially in the ventricles after burn injury
Numerous studies have revealed that severe burn injury dramatically increases the release of endogenous catecholamines epinephrine and norepinephrine. [3] In heart failure, another disease associated with increased catecholamine release, the expression levels of cardiac β-ARs are drastically different than that seen under normal conditions. [8] We first examined whether burn injury altered expression of the β-AR subtypes as well as the G-proteins most highly associated with their function. Prior to burn, left ventricular β1-AR protein expression was significantly higher than expression in the right ventricle (Fig 1A and 1B; p = 0.002). However, β1-AR protein expression was significantly increased (168%) in the right ventricle after burn injury but not in the left ventricle (p = 0.002). While there was a trend for stimulatory G-protein (Gαs) expression to be increased in the right ventricle after burn, this was not significant (Fig 1A and 1C). β2-AR protein expression was not altered in either ventricle after burn injury but there was significantly higher β2-AR expression in the left ventricle compared to the right (Fig 2A and 2B; p = 0.006). In contrast, the inhibitory G-protein (Gαi) was expressed higher in the left ventricles of burned animals (Fig 2A and 2C; p<0.0001). Burn injury did not alter β3-AR expression in either ventricle (Fig 3A and 3B).
Representative Western blots of β1-AR (A, B) and Gs (A, C) protein expression in right and left ventricles seven days post-burn. Controls were nonburned animals. The bar graphs show the ratio of protein to GAPDH. Data are expressed as the mean ± SEM. Statistical analysis was performed using a one-way ANOVA. n = 9–12; p<0.00001 for β1-AR; RV C: right ventricle control; RV B: right ventricle burned; LV C: left ventricle control; LV B: left ventricle burned; †, p<0.05 vs RV C.
Representative Western blots of β2-AR (A, B) and Gi (A, C) protein expression in right and left ventricles seven days post-burn. Controls were nonburned animals. The bar graphs show the ratio of protein to GAPDH. Data are expressed as the mean ± SEM. Statistical analysis was performed using a one-way ANOVA. n = 9–12; p<0.0001 for β2-AR; p = 0.011 for Gi; RV C: right ventricle control; RV B: right ventricle burned; LV C: left ventricle control; LV B: left ventricle burned; β-AR, beta adrenergic receptor; †, p<0.05 vs RV C; ‡, p<0.05 vs RV B.
Representative Western blots of β3-AR protein expression in right and left ventricles seven days post-burn. Controls were nonburned animals. The bar graphs show the ratio of protein to GAPDH. Data are expressed as the mean ± SEM. Statistical analysis was performed using a one-way ANOVA. n = 6; RV C: right ventricle control; RV B: right ventricle burned; LV C: left ventricle control; LV B: left ventricle burned; β-AR; beta adrenergic receptor.
Increased left ventricular gene expression of proteins involved in β-AR desensitization following burn injury
G protein coupled receptor kinase 2 (GRK2) and β-arrestin-1 are two proteins involved in β-AR desensitization to terminate signaling through the receptors in response to increased and/or prolonged stimulation by circulating catecholamines or administration of β-AR agonists. [15, 16] Similar to what has been reported in heart failure, we observed significantly increased β-arrestin-1 and GRK2 gene expression in the LV after burn injury (Fig 4A and 4B; p = 0.001; <0.0001). Neither GRK2 nor β-arrestin-1 gene expression was altered after burn injury in the RV. Previous studies in both human and animal subjects have shown that burn injury produces a systematic and prolonged increase in catecholamine levels [11, 17]. While we did not measure catecholamines directly in this study, the alterations in GRK2 and β-arrestin-1 mRNA are indicative of desensitization of left ventricular β-ARs due to overstimulation [18, 19]. This suspected desensitization may be the mechanism by which cAMP production and PKA activity are decreased despite β-AR expression remaining constant.
(A) β-arrestin 1 mRNA expression from right and left ventricles and (B) GRK2 mRNA gene from right and left ventricles at seven days post-burn. Data are expressed as the mean ±SEM. Statistical analysis was performed using a one-way ANOVA. n = 7–9; p = 0.001, <0.0001 respectively; RV C: right ventricle control; RV B: right ventricle burned; LV C: left ventricle control; LV B: left ventricle burned; GRK2, G-protein coupled receptor kinase 2; *, p<0.05 vs LV C; †, p<0.05 vs RV C; ‡, p<0.05 vs RV B.
Burn injury reduces left ventricular cAMP production and PKA activity
Following activation of β-ARs by catecholamines, G-proteins regulate adenylyl cyclase activity. The type of G-protein released from the β-AR complex determines whether adenylyl cyclase activity is inhibited (Gαi) or stimulated (Gαs). Adenylyl cyclase is the primary producer of cytosolic cAMP, the activator of PKA, a kinase that phosphorylates proteins that regulate cardiac contractility, relaxation, and function. [5] Surprisingly, despite a post-burn increase in β1-AR and Gαs protein expression in the right ventricle, cAMP production and PKA activity remained unchanged. In contrast, as would be expected with increased expression of Gαi, burn injury significantly reduced left ventricular cAMP production and PKA activity (Fig 5A and 5B; p = 0.006 and 0.004).
(A) cAMP production in membrane fractions isolated from right and left ventricles and (B) PKA activity in cytosolic fractions from right and left ventricles, seven days post-burn. Data are expressed as the mean ±SEM. Statistical analysis was performed using a one-way ANOVA. n = 6–9; p = 0.006 for cAMP; p = 0.004 for PKA; RV C: right ventricle control; RV B: right ventricle burned; LV C: left ventricle control; LV B: left ventricle burned; cAMP, cyclic adenosine monophosphate; PKA, protein kinase A; *, p<0.05 vs LV C; †, p<0.05 vs RV C; ‡, p<0.05 vs RV B.
Burn injury alters expression of VEGF mRNA in the left ventricle and IGF-1 mRNA in the right ventricle
Drake et al., showed, in two models of right ventricular failure, that vascular endothelial growth factor (VEGF) mRNA and insulin-like growth factor 1 (IGF-1) mRNA expression was significantly decreased. [20] Additionally, there is evidence that VEGF gene expression is upregulated upon β-AR stimulation [21]. In our study, VEGF-A mRNA expression was significantly decreased while expression of VEGF-B mRNA was significantly increased in the left ventricle post-burn (Fig 6A and 6B; p = 0.01; 0.002). There were no changes in expression of VEGF in the right ventricle. However, IGF-1 mRNA expression was significantly increased in the right ventricle with no statistical change observed in the left ventricle (Fig 6C; p = 0.02).
PCR measurement of VEGF-A (A), VEGF-B (B), and IGF1 (C) mRNA expression in right and left ventricles, seven days post-burn. Controls were nonburned animals. Data are expressed as the mean ± SEM. Statistical analysis was performed using a one-way ANOVA. n = 6–9; RV C: right ventricle control; RV B: right ventricle burned; LV C: left ventricle control; LV B: left ventricle burned; VEGF, vascular endothelial growth factor; IGF1, insulin-like growth factor 1; *, p<0.05 vs LV C; †, p<0.05 vs RV C; ‡, p<0.05 vs RV B.
Discussion
In disease conditions, sympathetic nervous system (SNS) tone is increased in response to either reduced cardiac output or contractility. The enhanced SNS tone causes an increased secretion of neurohormones such as norepinephrine and epinephrine. β-AR stimulation initially enhances cardiac contractility but prolonged catecholamine release and subsequent β-AR stimulation triggers a series of adaptive signaling cascades that will eventually produce cardiac dysfunction and, in some cases, heart failure. To date, there are very few mechanistic reports concerning the effect of prolonged catecholamine release in the right ventricle although there have been reports of interventricular differences in the response to β-AR stimulation. Molina et al. have shown that the response to short-term β-AR stimulation in the canine heart is significantly more robust in the right ventricle compared to the left ventricle [22]. Environmental stress conditions, which can involve increased catecholamine release, was associated with increase expression of the catecholamine synthesis enzyme phenylethanolamine N-methyltrasnferase as well as enhanced expression of β2-AR mRNA in the left ventricle [23]. However, the left ventricle has been the focus of most published research regarding β-AR overstimulation and cardiac dysfunction.
In heart failure, a disease state characterized by β-AR overstimulation, changes in β-AR density, signaling partners, and the termination of β-AR signaling have been well described [15, 24–27]. Sun et al. reported that total β-ARs (both β1- and β2-AR) were increased in the right ventricle of patients suffering from tetralogy of Fallot. This was accompanied by increased adenylyl cyclase activity which the authors attributed to β-ARs coupling with Gαs [28]. However, in contrast with the data reported by Sun et al., we did not see a concomitant increase in either cAMP or PKA in the right ventricle. While there are clear differences between our disease model and that reported by Sun et al., we hypothesize that our lack of change in cAMP levels could be due to the activation of other signaling pathways that either modulate cAMP levels or change the subcellular location of adenylyl cyclase.
β2-ARs can couple with both inhibitory and stimulatory G-proteins and, in the presence of chronic stimulation, it has been shown that β2-ARs begin to preferentially couple with Gαi [15, 24, 29]. This may be due to increased Gαi expression after prolonged catecholamine release [30]. Gαi inhibits adenylyl cyclase to reduce cAMP production and thus PKA activity. Similar to what has been shown in other disease conditions characterized by chronic stimulation of β-ARs, we observed both increased Gαi expression and reduced cAMP production and PKA activity in the left ventricle after burn injury [15, 31]. The effect of prolonged increases in catecholamine release on β3-ARs is not as clearly defined as the other β-ARs. Some have reported increased β3-AR expression after chronic stimulation whereas others and the present study were unable to determine any differences [19, 32].
Increased GRK2 and β-arrestin gene expression and/or protein expression has been associated with β-AR desensitization and downregulation after chronic β-AR stimulation [15, 24, 25]. Accordingly, we observed increased GRK2 and β-arrestin mRNA expression in the left ventricle after burn injury. This finding corroborates earlier reports of decreased β-AR affinity and the inability of exogenous β-AR stimulation to augment calcium release in burned rat cardiomyocytes [12, 33].
A previous study also reported decreased cAMP content as well as PKA activity for up to two weeks after burn injury [12]. These changes in activity were not associated with changes in the levels of PKA [12]. PKA, after activation by the binding of cAMP, phosphorylates numerous proteins underlying the mechanisms controlling cardiac lusitropy, chronotropy, and inotropy. Alterations in PKA activity can result in either hypo-phosphorylation or hyper-phosphorylation, depending upon the substrate, and can have profound effects on cardiac function [13, 34, 35]. Our finding of reduced cAMP production and PKA activity provide further evidence for the supposition that elevated catecholamine levels after burn injury leads to β-AR desensitization.
VEGF mRNA expression can be increased in a β-AR/cAMP/PKA dependent mechanism [21]. Both VEGF-A and VEGF-B regulate angiogenesis and are key components of the wound healing process. The two VEGF variants are usually co-expressed and can be found as heterodimers [36]. VEGF signaling is important for normal cardiac signaling as evidenced by the lethality of VEGF-A knockdown. Conversely, VEGF-B knockout mice are viable but have reduced cardiac size and face difficulty recovering from cardiac insults [37, 38]. Additionally, vascular diseases such as heart failure have been associated with an increase in VEGF levels [39]. We observed a decrease in left ventricular VEGF-A mRNA expression with a concurrent increase in VEGF-B mRNA expression post-burn. Increased circulating VEGF has been shown to occur in human burn patients, remains elevated until wound closure, and is associated with edema [40]. In the myocardium, increased expression of VEGF-B is associated with left ventricular cardiac hypertrophy and has been shown to occur in response to neurohormone administration. [41]. At the time-point measured in this study, we did not observe hypertrophy. However, future long-term studies will investigate whether the changes we have observed at seven days post-injury will lead to cardiac hypertrophy.
Drake et al. showed that IGF-1 gene expression was significantly increased in right ventricular hypertrophy but not in right ventricular failure [20]. As its name suggests, IGF-1 promotes growth and may contribute to the development of both physiological and pathological cardiac hypertrophy. Additionally, IGF-1 expression is increased in the presence of cardiac disease and dysfunction [42, 43]. Thus, the increase in IGF-1 may be the body’s attempt to compensate for alterations in cardiac function and morphology. We also report an increase in right ventricular IGF-1 expression following burn injury. Burn injury may promote pro-hypertrophic signaling in the right ventricle but additional studies are needed to confirm.
Changes in β-AR density, cAMP production, and GRK2 expression occurs in both right and left heart failure. However, the extent of signaling changes in the right ventricle appears to depend upon the cause of failure [44]. Therefore, the increased catecholamine release after burn injury may not be sufficient alone to produce alterations in β-AR signaling that would result in right ventricular failure. Indeed, it is often hypothesized that volume overload during resuscitation is the primary cause of right ventricular failure in burned pediatric patients [45].
Conclusions
While our study did not observe any clear indications of right ventricular or left ventricular failure after burn injury, our data does indicate that burn injury affects the β-AR signaling pathway in the RV independently of the LV. While the LV displayed characteristic perturbations of canonical β-AR signaling expected with enhanced catecholamine release after burn injury, these data indicated non-canonical β-AR signaling may be occurring in the RV as cAMP production and PKA activity were unchanged. Our future directions are to investigate these biventricular differences over a time-course ranging from 24 hours post-injury up to 28 days post-injury.
References
- 1. Guillory An, Clayton Rp, Herndon Dn, Finnerty Cc. Cardiovascular Dysfunction Following Burn Injury: What We Have Learned From Rat And Mouse Models. International Journal Of Molecular Sciences. 2016;17(1). Epub 2016/01/06. pmid:26729111.
- 2. Williams Fn, Herndon Dn, Suman Oe, Lee Jo, Norbury Wb, Branski Lk, Et Al. Changes In Cardiac Physiology After Severe Burn Injury. Journal Of Burn Care & Research: Official Publication Of The American Burn Association. 2011;32(2):269–74. Epub 2011/01/14. pmid:21228708.
- 3. Kulp Ga, Herndon Dn, Lee Jo, Suman Oe, Jeschke Mg. Extent And Magnitude Of Catecholamine Surge In Pediatric Burned Patients. Shock. 2010;33(4):369–74. Epub 2010/04/22. pmid:20407405.
- 4. Pereira Ct, Barrow Re, Sterns Am, Hawkins Hk, Kimbrough Cw, Jeschke Mg, Et Al. Age-Dependent Differences In Survival After Severe Burns: A Unicentric Review Of 1,674 Patients And 179 Autopsies Over 15 Years. Journal Of The American College Of Surgeons. 2006;202(3):536–48. Epub 2006/02/28. pmid:16500259.
- 5. Katz Am, Lorell Bh. Regulation Of Cardiac Contraction And Relaxation. Circulation. 2000;102(20 Suppl 4):Iv69–74. Epub 2000/11/18. pmid:11080134.
- 6. Raab W. Key Position Of Catecholamines In Functional And Degenerative Cardiovascular Pathology. Am J Cardiol. 1960;5:571–8. Epub 1960/05/01. pmid:14435598.
- 7. Molkentin Jd, Dorn Gw 2nd. Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy. Annual Review Of Physiology. 2001;63:391–426. Epub 2001/02/22. pmid:11181961.
- 8. Lefkowitz Rj, Rockman Ha, Koch Wj. Catecholamines, Cardiac Beta-Adrenergic Receptors, And Heart Failure. Circulation. 2000;101(14):1634–7. Epub 2000/04/12. pmid:10758041.
- 9. Irlbeck M, Muhling O, Iwai T, Zimmer Hg. Different Response Of The Rat Left And Right Heart To Norepinephrine. Cardiovascular Research. 1996;31(1):157–62. Epub 1996/01/01. pmid:8849601.
- 10. Brooks Nc, Song J, Boehning D, Kraft R, Finnerty Cc, Herndon Dn, Et Al. Propranolol Improves Impaired Hepatic Phosphatidylinositol 3-Kinase/Akt Signaling After Burn Injury. Mol Med. 2012;18:707–11. Epub 2012/03/08. pmid:22396018.
- 11. Herndon Dn, Wilmore Dw, Mason Ad Jr. Development And Analysis Of A Small Animal Model Simulating The Human Postburn Hypermetabolic Response. The Journal Of Surgical Research. 1978;25(5):394–403. Epub 1978/11/01. pmid:713539.
- 12. Wang C, Martyn Ja. Burn Injury Alters Beta-Adrenergic Receptor And Second Messenger Function In Rat Ventricular Muscle. Critical Care Medicine. 1996;24(1):118–24. Epub 1996/01/01. pmid:8565516.
- 13. Guillory An, Yin X, Wijaya Cs, Diaz Diaz Ac, Rababa’h A, Singh S, Et Al. Enhanced Cardiac Function In Gravin Mutant Mice Involves Alterations In The β-Adrenergic Receptor Signaling Cascade. Plos One. 2013;8(9):E74784. pmid:24058627.
- 14. Schmittgen Td, Livak Kj. Analyzing Real-Time Pcr Data By The Comparative C(T) Method. Nature Protocols. 2008;3(6):1101–8. Epub 2008/06/13. pmid:18546601.
- 15. Lohse Mj, Engelhardt S, Eschenhagen T. What Is The Role Of Beta-Adrenergic Signaling In Heart Failure? Circulation Research. 2003;93(10):896–906. Epub 2003/11/15. pmid:14615493.
- 16. Ungerer M, Parruti G, Bohm M, Puzicha M, Deblasi A, Erdmann E, Et Al. Expression Of Beta-Arrestins And Beta-Adrenergic Receptor Kinases In The Failing Human Heart. Circ Res. 1994;74(2):206–13. Epub 1994/02/01. pmid:8293560.
- 17. Jeschke Mg, Gauglitz Gg, Kulp Ga, Finnerty Cc, Williams Fn, Kraft R, Et Al. Long-Term Persistance Of The Pathophysiologic Response To Severe Burn Injury. Plos One. 2011;6(7):E21245. Epub 2011/07/27. pmid:21789167.
- 18. Fu Q, Xu B, Parikh D, Cervantes D, Xiang Yk. Insulin Induces Irs2-Dependent And Grk2-Mediated B2ar Internalization To Attenuate Bar Signaling In Cardiomyocytes. Cell Signal. 2015;27(3):707–15. pmid:25460042.
- 19. Port Jd, Bristow Mr. Altered Beta-Adrenergic Receptor Gene Regulation And Signaling In Chronic Heart Failure. J Mol Cell Cardiol. 2001;33(5):887–905. Epub 2001/05/10. pmid:11343413.
- 20. Drake Ji, Bogaard Hj, Mizuno S, Clifton B, Xie B, Gao Y, Et Al. Molecular Signature Of A Right Heart Failure Program In Chronic Severe Pulmonary Hypertension. American Journal Of Respiratory Cell And Molecular Biology. 2011;45(6):1239–47. Epub 2011/07/02. pmid:21719795.
- 21. Fredriksson Jm, Lindquist Jm, Bronnikov Ge, Nedergaard J. Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression In Brown Adipocytes Through A Beta -Adrenoreceptor/Camp/Protein Kinase A Pathway Involving Src But Independently Of Erk1/2. J Biol Chem. 2000;275(18):13802–11. Epub 2000/05/02. pmid:10788502.
- 22. Molina Ce, Johnson Dm, Mehel H, Spätjens Rl, Mika D, Algalarrondo V, Et Al. Interventricular Differences In B-Adrenergic Responses In The Canine Heart: Role Of Phosphodiesterases. J Am Heart Assoc. 2014;3(3):E000858. Epub 2014/06/05. pmid:24904016.
- 23. Spasojevic N, Gavrilovic L, Dronjak S. Regulation Of Catecholamine-Synthesising Enzymes And Beta-Adrenoceptors Gene Expression In Ventricles Of Stressed Rats. Physiol Res. 2011;60 Suppl 1:S171–6. Epub 2011/07/19. pmid:21777029.
- 24. Daaka Y, Luttrell Lm, Lefkowitz Rj. Switching Of The Coupling Of The Beta2-Adrenergic Receptor To Different G Proteins By Protein Kinase A. Nature. 1997;390(6655):88–91. Epub 1997/11/18. pmid:9363896.
- 25. Luttrell Lm, Lefkowitz Rj. The Role Of Beta-Arrestins In The Termination And Transduction Of G-Protein-Coupled Receptor Signals. J Cell Sci. 2002;115(Pt 3):455–65. Epub 2002/02/28. pmid:11861753.
- 26. Pitcher Ja, Freedman Nj, Lefkowitz Rj. G Protein-Coupled Receptor Kinases. Annu Rev Biochem. 1998;67:653–92. Epub 1998/10/06. pmid:9759500.
- 27. Iaccarino G, Tomhave Ed, Lefkowitz Rj, Koch Wj. Reciprocal In Vivo Regulation Of Myocardial G Protein-Coupled Receptor Kinase Expression By Beta-Adrenergic Receptor Stimulation And Blockade. Circulation. 1998;98(17):1783–9. Epub 1998/10/27. pmid:9788834.
- 28. Sun Ls, Du F, Quaegebeur Jm. Right Ventricular Infundibular Beta-Adrenoceptor Complex In Tetralogy Of Fallot Patients. Pediatric Research. 1997;42(1):12–6. Epub 1997/07/01. pmid:9212031.
- 29. Xiao Rp. Beta-Adrenergic Signaling In The Heart: Dual Coupling Of The Beta2-Adrenergic Receptor To G(S) And G(I) Proteins. Sci Stke. 2001;2001(104):Re15. pmid:11604549.
- 30. Feldman Am, Cates Ae, Bristow Mr, Van Dop C. Altered Expression Of Alpha-Subunits Of G Proteins In Failing Human Hearts. J Mol Cell Cardiol. 1989;21(4):359–65. Epub 1989/04/01. pmid:2501499.
- 31. Neumann J, Schmitz W, Scholz H, Von Meyerinck L, Doring V, Kalmar P. Increase In Myocardial Gi-Proteins In Heart Failure. Lancet. 1988;2(8617):936–7. Epub 1988/10/22. pmid:2902384.
- 32. Fischer V, Gabauer I, Tillinger A, Novakova M, Pechan I, Krizanova O, Et Al. Heart Adrenoceptor Gene Expression And Binding Sites In The Human Failing Heart. Ann N Y Acad Sci. 2008;1148:400–8. Epub 2009/01/06. pmid:19120134.
- 33. Koshy Us, Burton Kp, Le Th, Horton Jw. Altered Ionic Calcium And Cell Motion In Ventricular Myocytes After Cutaneous Thermal Injury. Journal Of Surgical Research. 1997;68(2):133–8. pmid:9184671.
- 34. El-Armouche A, Eschenhagen T. Beta-Adrenergic Stimulation And Myocardial Function In The Failing Heart. Heart Fail Rev. 2009;14(4):225–41. Epub 2008/12/30. pmid:19110970.
- 35. Bartel S, Stein B, Eschenhagen T, Mende U, Neumann J, Schmitz W, Et Al. Protein Phosphorylation In Isolated Trabeculae From Nonfailing And Failing Human Hearts. Molecular And Cellular Biochemistry. 1996;157(1–2):171–9. Epub 1996/04/12. pmid:8739244.
- 36. Ferrara N. Vascular Endothelial Growth Factor: Molecular And Biological Aspects. Current Topics In Microbiology And Immunology. 1999;237:1–30. Epub 1999/01/20. pmid:9893343.
- 37. Bellomo D, Headrick Jp, Silins Gu, Paterson Ca, Thomas Ps, Gartside M, Et Al. Mice Lacking The Vascular Endothelial Growth Factor-B Gene (Vegfb) Have Smaller Hearts, Dysfunctional Coronary Vasculature, And Impaired Recovery From Cardiac Ischemia. Circ Res. 2000;86(2):E29–35. Epub 2000/02/10. pmid:10666423.
- 38. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’shea Ks, Et Al. Heterozygous Embryonic Lethality Induced By Targeted Inactivation Of The Vegf Gene. Nature. 1996;380(6573):439–42. Epub 1996/04/04. pmid:8602242.
- 39. Debette S, Visvikis-Siest S, Chen Mh, Ndiaye Nc, Song C, Destefano A, Et Al. Identification Of Cis- And Trans-Acting Genetic Variants Explaining Up To Half The Variation In Circulating Vascular Endothelial Growth Factor Levels. Circ Res. 2011;109(5):554–63. Epub 2011/07/16. pmid:21757650.
- 40. Infanger M, Schmidt O, Kossmehl P, Grad S, Ertel W, Grimm D. Vascular Endothelial Growth Factor Serum Level Is Strongly Enhanced After Burn Injury And Correlated With Local And General Tissue Edema. Burns. 2004;30(4):305–11. pmid:15145186.
- 41. Hudlicka O, Brown M, Egginton S. Angiogenesis In Skeletal And Cardiac Muscle. Physiol Rev. 1992;72(2):369–417. Epub 1992/04/01. pmid:1372998.
- 42. Pucci A, Zanini C, Granata R, Ghignone R, Iavarone A, Broglio F, Et Al. Myocardial Insulin-Like Growth Factor-1 And Insulin-Like Growth Factor Binding Protein-3 Gene Expression In Failing Hearts Harvested From Patients Undergoing Cardiac Transplantation. J Heart Lung Transplant. 2009;28(4):402–5. Epub 2009/04/01. pmid:19332270.
- 43. Abe N, Matsunaga T, Kameda K, Tomita H, Fujiwara T, Ishizaka H, Et Al. Increased Level Of Pericardial Insulin-Like Growth Factor-1 In Patients With Left Ventricular Dysfunction And Advanced Heart Failure. Journal Of The American College Of Cardiology. 2006;48(7):1387–95. Epub 2006/10/03. pmid:17010800.
- 44. Piao L, Fang Yh, Parikh Ks, Ryan Jj, D’souza Km, Theccanat T, Et Al. Grk2-Mediated Inhibition Of Adrenergic And Dopaminergic Signaling In Right Ventricular Hypertrophy: Therapeutic Implications In Pulmonary Hypertension. Circulation. 2012;126(24):2859–69. Epub 2012/11/06. pmid:23124027.
- 45. Williams Fn, Herndon Dn, Hawkins Hk, Lee Jo, Cox Ra, Kulp Ga, Et Al. The Leading Causes Of Death After Burn Injury In A Single Pediatric Burn Center. Crit Care. 2009;13(6):R183. Epub 2009/11/19. pmid:19919684.